Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Autoinjectors market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.8% during the forecast period.
This report presents the market size and development trends by detailing the Autoinjectors market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Autoinjectors market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Autoinjectors industry and will help you to build a panoramic view of the industrial development.
Autoinjectors Market, By Type:
Fillable Autoinjectors
Prefilled Autoinjectors
Autoinjectors Market, By Application:
Rheumatoid Arthritis
Anaphylaxis
Multiple Sclerosis
Others
Some of the leading players are as follows:
Mylan
Pfizer
Sanofi
Unilife
Biogen Idec
Ypsomed Holdings
Scandinavian Health Limited (SHL)
Antares Pharma
Novartis International
Becton Dickinson
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Autoinjectors Market: Technology Type Analysis
-
4.1 Autoinjectors Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Autoinjectors Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Fillable Autoinjectors
4.3.2 Prefilled Autoinjectors
5 Autoinjectors Market: Product Analysis
-
5.1 Autoinjectors Product Market Share Analysis, 2018 & 2026
-
5.2 Autoinjectors Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Autoinjectors Market: Application Analysis
-
6.1 Autoinjectors Application Market Share Analysis, 2018 & 2026
-
6.2 Autoinjectors Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Rheumatoid Arthritis
6.3.2 Anaphylaxis
6.3.3 Multiple Sclerosis
6.3.4 Others
7 Autoinjectors Market: Regional Analysis
-
7.1 Autoinjectors Regional Market Share Analysis, 2018 & 2026
-
7.2 Autoinjectors Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Mylan
9.1.1 Mylan Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Pfizer
9.2.1 Pfizer Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Sanofi
9.3.1 Sanofi Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Unilife
9.4.1 Unilife Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Biogen Idec
9.5.1 Biogen Idec Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Ypsomed Holdings
9.6.1 Ypsomed Holdings Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Scandinavian Health Limited (SHL)
9.7.1 Scandinavian Health Limited (SHL) Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Antares Pharma
9.8.1 Antares Pharma Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Novartis International
9.9.1 Novartis International Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Becton Dickinson
9.10.1 Becton Dickinson Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 101 Figures and 165 Tables)
Figure Fillable Autoinjectors Autoinjectors market, 2015 - 2026 (USD Million)
Figure Prefilled Autoinjectors Autoinjectors market, 2015 - 2026 (USD Million)
Figure Rheumatoid Arthritis market, 2015 - 2026 (USD Million)
Figure Anaphylaxis market, 2015 - 2026 (USD Million)
Figure Multiple Sclerosis market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Autoinjectors market, by country, 2015 - 2026 (USD Million)
-
Table North America Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table North America Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table North America Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Canada Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Canada Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Europe Autoinjectors market, by country, 2015 - 2026 (USD Million)
-
Table Europe Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Europe Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Europe Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Germany Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Germany Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table France Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table France Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Italy Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Italy Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Spain Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Spain Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Autoinjectors market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table China Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table China Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Japan Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Japan Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table India Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table India Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Autoinjectors market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table MEA Autoinjectors market, by country, 2015 - 2026 (USD Million)
-
Table MEA Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table MEA Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table MEA Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Autoinjectors market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Autoinjectors market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Autoinjectors market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Mylan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Unilife Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biogen Idec Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ypsomed Holdings Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Scandinavian Health Limited (SHL) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Antares Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Becton Dickinson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
